Search Medical Condition
Please enter condition
Please choose location

Anorexia Clinical Trials

A listing of Anorexia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (50) clinical trials

Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients

Cannabis has long been suggested to stimulate appetite, decrease nausea and vomiting, and improve quality of life in cancer patients. Studies on the efficacy of cannabis for improving CACS and S-NIS have had mixed results. After trials showing improvement in weight gain among AIDS patients, cannabinoids were tested on cancer ...

Phase N/A

The Role of Lactobacillus Reuteri in Children and Adolescents With Anorexia Nervosa

Pediatric patients with AN and constipation referred to gastroenterologist for nutritional rehabilitation at the Department of Pediatric Gastroenterology, Hepatology and Nutrition, Clinical Hospital Center Sestre Milosrdnice, Zagreb, approximately 30 children, will be asked to participate. The evaluation of patients will be conducted through APA DSM-V diagnostic criteria for anorexia nervosa ...


Cephalic Phase in Anorexia Nervosa Bulimia Nervosa and Obese Binge Eaters

Food stimulation of gastric and pancreatic secretion is classically divided into cephalic, gastric and intestinal phases. Cephalic phase refers to a simultaneous activation of gastrointestinal motility, gastric acid and pancreatic enzyme secretion ,as well as, release of hormones from the endocrine pancreas which occurs through activation of vagal -efferents as ...

Phase N/A

Adaptive Treatment for Adolescent Anorexia Nervosa

Potential subjects aged 12 to 18 with anorexia nervosa (AN) will be recruited from Stanford University, University of California, San Francisco, and other bay-area medical programs and clinics. If participants are deemed eligible, participants will be invited for a baseline interview (about 2 hours in duration) during which the investigators ...

Phase N/A

Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy

The syndrome of anorexia-cachexie, which accompanies numerous cancers is a major comorbidity which compromises the forecast of these patients. Several cytokines pro-inflammatory as interleukines IL1 , IL6 or TNFa participate in the physiopathology of this syndrome at the man and the animal. Besides, it is now established that different neuronal ...

Phase N/A

Bone Mass Changes in Anorexia Nervosa Patient Followed During 4 Years

The mechanism of bone loss in anorexia nervosa is complex. Marrow adipose tissue seems to play a role in the regulation of bone metabolism. Adipocytes secrete cytokines and adipokines that either stimulate or inhibit adjacent osteoblasts. This study consist to explore the relationship in anorexia nervosa patients with change in ...

Phase N/A

rTMS and Body Shape Perception

Anorexia nervosa (AN) is a frequent, potentially life-threatening eating disorder characterized by a resistance to maintaining body weight at or above a minimally normal weight for age and height, an intense fear of weight gain or being "fat" even though underweight, a loss of menstrual periods in girls and women ...

Phase N/A

Effects of Anorexia Nervosa on Peak Bone Mass

Given the increasing prevalence of AN, its profound consequences on bone health, and lack of optimal treatment interventions, these studies will provide critical data needed to identify optimal treatment strategies for this severe co-morbid disease using state- of- the- art endpoints of BMD, bone microarchitecture and strength. Although both low ...


Therapeutic Drug Monitoring in Child and Adolescent Psychiatry

We aim to analyse in adolescents with mental illness effectiveness, side effects, and serum level concentrations of antipsychotics (olanzapine and aripiprazole), antidepressants (Duloxetine, Atomoxetine) by means of "Therapeutic Drug Monitoring" (TDM) in order to optimize dosage - effect relations and minimize unwanted side effects. Therapeutic drug monitoring is becoming a ...

Phase N/A

Evaluation of Brain Opioid Receptor Activity in Anorexia Nervosa : a PET [11C]Diprenorphine Study

The place of opioid system in anorexia nervosa (AN) physiopathology is still unclear. Conflicting results were published on cerebral spinal fluid or peripheral levels in anorexia nervosa. However, no data have been reported on opioid cerebral activity. Diprenorphine is a ligand with non-selective binding to opiate receptors , and capable ...

Phase N/A